SCHEMBL9987572

SCHEMBL9987572

COc1cc2c(nc1OC)c(-c1cc3cc(F)cnc3n1S(=O)(=O)c1ccc(C)cc1)cn2C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
ALDH3A1 P30838 3/20 0.35
TSHR P16473 3/20 0.35
LMNA P02545 1/20 0.35
PTGDR2 Q9Y5Y4 3/20 0.34
CYP3A4 P08684 3/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.31
PTGDR Q13258 1/20 0.31
SCN9A Q15858 2/20 0.31
ACLY P53396 1/20 0.31
PSEN1 P49768 1/20 0.30
PSEN2 P49810 1/20 0.30
APH1B Q8WW43 1/20 0.30
NCSTN Q92542 1/20 0.30
APH1A Q96BI3 1/20 0.30
PSENEN Q9NZ42 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2985981 0.91 PIM1 (0.36) PIM1PIM2ALDH3A1TSHRLMNA
SCHEMBL2986526 0.86 PIM1 (0.35) PIM1PIM2ALDH3A1TSHRLMNA
SCHEMBL2991201 0.86 PIM1 (0.35) PIM1PIM2ALDH3A1TSHRLMNA
SCHEMBL2991179 0.82 NPC1 (0.36) PIM1PIM2ALDH1A1
SCHEMBL2988252 0.81 LMNA (0.34) PIM1PIM2ALDH3A1TSHRLMNA
SCHEMBL2990014 0.80 PTGDR2 (0.42) ALDH3A1TSHRPTGDR2CYP3A4ALDH1A1
SCHEMBL2991843 0.78 PIM1 (0.36) PIM1PIM2ALDH3A1TSHRLMNA
SCHEMBL13103442 0.78 L3MBTL1 (0.37) PIM1PIM2ALDH3A1TSHRLMNA
SCHEMBL13093819 0.76 L3MBTL1 (0.42) ALDH3A1TSHRLMNAPTGDR2ALDH1A1
SCHEMBL1749068 0.75 TP53 (0.41) PIM1PIM2ALDH3A1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799691-B1 NOVEL BIS-AZAINDOLE DERIVATIVES, PREPARATION AND PHARMACEUTICAL USE THEREOF AS KINASE INHIBITORS AVENTIS PHARMA SA (FR) 2011-12-21 EP disclosed